Literature DB >> 29083220

Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.

Corey R Roos1, Sarah Bowen2, Katie Witkiewitz1.   

Abstract

OBJECTIVE: Few studies have evaluated moderators of mindfulness-based relapse prevention (MBRP) for substance use disorders (SUDs). We tested whether baseline patterns of scores for SUD symptom severity and depression and anxiety symptoms moderated the efficacy of MBRP.
METHOD: We used a latent class moderation approach with data from a randomized trial of MBRP compared to cognitive-behavioral relapse prevention and treatment as usual (TAU; Bowen et al., 2014; N = 286, 71.8% male, 48.4% non-White, mean age = 38.44 years, SD = 10.92) and a randomized trial comparing MBRP to TAU (Bowen et al., 2009; N = 168, 63.7% male, 44.6% non-White, mean age = 40.45, SD = .28). Indicators for the latent class models were measures of SUD severity (Severity of Dependence Scale and Short Inventory of Problems), depression symptoms (Beck Depression Inventory), and anxiety symptoms (Beck Anxiety Inventory).
RESULTS: In both trials, 3 latent classes provided the best fit: a high-high class characterized by high SUD severity and depression and anxiety symptoms, a high-low class characterized by high SUD severity and low depression and anxiety symptoms, and a low-low class characterized by low SUD severity and depression and anxiety symptoms. In both trials, we found significant latent Class × Treatment interaction effects: There were significant and large effects of MBRP on substance use outcomes in the high-high and high-low classes, but no MBRP effect in the low-low class.
CONCLUSION: MBRP may be an optimal treatment for preventing relapse among clients with severe levels of SUD symptoms and depression and anxiety symptoms, as well as clients with only severe SUD symptoms. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 29083220      PMCID: PMC5679292          DOI: 10.1037/ccp0000249

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  32 in total

Review 1.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain?

Authors:  Judson A Brewer; Sarah Bowen; Joseph T Smith; G Alan Marlatt; Marc N Potenza
Journal:  Addiction       Date:  2010-10       Impact factor: 6.526

Review 3.  Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.

Authors:  A Thomas McLellan; James R McKay; Robert Forman; John Cacciola; Jack Kemp
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

4.  Randomized trial comparing mindfulness-based relapse prevention with relapse prevention for women offenders at a residential addiction treatment center.

Authors:  Katie Witkiewitz; Kaitlin Warner; Betsy Sully; Adria Barricks; Connie Stauffer; Brian L Thompson; Jason B Luoma
Journal:  Subst Use Misuse       Date:  2014-04       Impact factor: 2.164

5.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

6.  Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy.

Authors:  Kate B Wolitzky-Taylor; Joanna J Arch; David Rosenfield; Michelle G Craske
Journal:  J Consult Clin Psychol       Date:  2012-07-23

Review 7.  The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis.

Authors:  Jacob Piet; Esben Hougaard
Journal:  Clin Psychol Rev       Date:  2011-05-15

8.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

Review 9.  Relapse prevention for alcohol and drug problems: that was Zen, this is Tao.

Authors:  Katie Witkiewitz; G Alan Marlatt
Journal:  Am Psychol       Date:  2004 May-Jun

10.  Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial.

Authors:  Eric L Garland; Amelia Roberts-Lewis; Christine D Tronnier; Rebecca Graves; Karen Kelley
Journal:  Behav Res Ther       Date:  2015-11-27
View more
  25 in total

1.  Prevalence of Mental Health Problems and Willingness to Participate in a Mindfulness Treatment: An Examination among Veterans Injured in Combat.

Authors:  Adrian J Bravo; Katie Witkiewitz; Michelle L Kelley; Jason C Redman
Journal:  Mindfulness (N Y)       Date:  2018-11-10

Review 2.  Cognitive training as a component of treatment of alcohol use disorder: A review.

Authors:  Sara Jo Nixon; Ben Lewis
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

3.  Triggers of Lapse and Relapse of Diet and Exercise in Behavioral Weight Loss.

Authors:  Charles Swencionis; Lucia Smith-Wexler; Michelle R Lent; Christopher Cimino; C J Segal-Isaacson; Mindy Ginsberg; Arlene Caban-Pocai; Sylvia Wassertheil-Smoller; John L Theodore; Judith Wylie-Rosett
Journal:  Obesity (Silver Spring)       Date:  2019-04-29       Impact factor: 5.002

4.  Acceptability of mindfulness-based interventions for substance use disorder: A systematic review.

Authors:  Tara Bautista; Dara James; Hortensia Amaro
Journal:  Complement Ther Clin Pract       Date:  2019-02-20       Impact factor: 2.446

Review 5.  Mindfulness-based interventions for addictions among diverse and underserved populations.

Authors:  Claire Adams Spears
Journal:  Curr Opin Psychol       Date:  2018-12-27

Review 6.  Mindfulness-based interventions for addictive behaviors: Implementation issues on the road ahead.

Authors:  Adam D Wilson; Corey R Roos; Charles S Robinson; Elena R Stein; Jacob A Manuel; Matthew C Enkema; Sarah Bowen; Katie Witkiewitz
Journal:  Psychol Addict Behav       Date:  2017-10-26

7.  The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.

Authors:  Victoria R Votaw; Matthew R Pearson; Elena Stein; Katie Witkiewitz
Journal:  Alcohol Clin Exp Res       Date:  2020-02-06       Impact factor: 3.455

8.  The Role of Affect in Psychosocial Treatments for Substance Use Disorders.

Authors:  Julia E Swan; Victoria R Votaw; Elena R Stein; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-06-01

9.  Addictive Behavior Change and Mindfulness-Based Interventions: Current Research and Future Directions.

Authors:  Frank J Schwebel; J Richard Korecki; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-02-15

10.  Approach coping and substance use outcomes following mindfulness-based relapse prevention among individuals with negative affect symptomatology.

Authors:  Corey Roos; Sarah Bowen; Katie Witkiewitz
Journal:  Mindfulness (N Y)       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.